Capecitabine and Tipifarnib in Treating Women With Taxane-Resistant Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Recurrent Breast Cancer|Stage IV Breast Cancer
Interventions: DRUG: tipifarnib|DRUG: capecitabine
Sponsor: National Cancer Institute (NCI)